Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05752552 |
| Title | Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | DeuterOncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD | FRA | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Roi Albert II - UC Louvain | Brussels | Belgium | Details | |||
| UZA | Edegem | Belgium | Details | |||
| Universitair Ziekenhuis Gent | Ghent | 9000 | Belgium | Details | ||
| Centre Georges-François Leclerc - CHU Dijon | Dijon | France | Details | |||
| Institut Cœur Poumon - CHU Lille | Lille | France | Details | |||
| Centre Léon Bérard | Lyon | France | Details | |||
| Radboud UMC | Nijmegen | Netherlands | Details | |||
| Erasmus Medical Centre | Rotterdam | Netherlands | Details |